Unlike conventional PD-L1 immunohistochemistry, MRI-based radiomics capture microstructural changes in tumor tissue through whole-tumor texture analysis and predict immunotherapy response more accurately than PD-L1 expression alone [29,33]. The gene discussed is CD274; the disease is neoplasm.